Why Shares of Cassava Sciences Jumped Last Week

Why Shares of Cassava Sciences Jumped Last Week

Source: 
Motley Fool
snippet: 
  • The company has a small pipeline.
  • Cassava also released data showing that Simufilam could be useful as an oncology drug.
  • The clinical-stage biotech company lost $24.3 million in the first quarter.